Biostage Stock Target Price
BSTGDelisted Stock | USD 4.20 0.09 2.10% |
Biostage fundamentals help investors to digest information that contributes to Biostage's financial success or failures. It also enables traders to predict the movement of Biostage OTC Stock. The fundamental analysis module provides a way to measure Biostage's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biostage otc stock.
Biostage |
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
All Next | Launch Module |
Biostage Fundamentals
Return On Equity | -4.92 | |||
Return On Asset | -2.11 | |||
Current Valuation | 78.64 M | |||
Shares Outstanding | 11.64 M | |||
Shares Owned By Insiders | 50.95 % | |||
Number Of Shares Shorted | 121.66 K | |||
Price To Earning | (0.16) X | |||
Price To Book | 28.47 X | |||
EBITDA | (8.36 M) | |||
Net Income | (7.98 M) | |||
Cash And Equivalents | 4.64 M | |||
Cash Per Share | 0.40 X | |||
Total Debt | 115 K | |||
Debt To Equity | 0.04 % | |||
Current Ratio | 2.26 X | |||
Book Value Per Share | (0.16) X | |||
Cash Flow From Operations | (2.63 M) | |||
Short Ratio | 3.35 X | |||
Earnings Per Share | (0.89) X | |||
Target Price | 3.0 | |||
Beta | -0.91 | |||
Market Capitalization | 73.82 M | |||
Total Asset | 1.87 M | |||
Retained Earnings | (65.78 M) | |||
Working Capital | 7.23 M | |||
Current Asset | 7.88 M | |||
Current Liabilities | 654 K | |||
Net Asset | 1.87 M |
About Biostage Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biostage's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biostage using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biostage based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |